These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22433713)

  • 1. Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.
    Ling J; Kumar R
    Cancer Lett; 2012 Sep; 322(2):119-26. PubMed ID: 22433713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Breast Cancer Signaling via Phytomedicine and Nanomedicine.
    Ansari JA; Malik JA; Ahmed S; Bhat FA; Khanam A; Mir SA; Abouzied AS; Ahemad N; Anwar S
    Pharmacology; 2023; 108(6):504-520. PubMed ID: 37748454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.
    Auphan N; DiDonato JA; Rosette C; Helmberg A; Karin M
    Science; 1995 Oct; 270(5234):286-90. PubMed ID: 7569976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of NFkB is a novel mechanism of pro-survival activity of glucocorticoids in breast cancer cells.
    Khan S; Lopez-Dee Z; Kumar R; Ling J
    Cancer Lett; 2013 Aug; 337(1):90-5. PubMed ID: 23693080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer.
    Mitre-Aguilar IB; Cabrera-Quintero AJ; Zentella-Dehesa A
    Int J Clin Exp Pathol; 2015; 8(1):1-10. PubMed ID: 25755688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells.
    Ritter HD; Mueller CR
    BMC Cancer; 2014 Apr; 14():275. PubMed ID: 24755251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of glucocorticoid signaling on tumor progression.
    Volden PA; Conzen SD
    Brain Behav Immun; 2013 Mar; 30 Suppl(0):S26-31. PubMed ID: 23164950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.
    Tornatore L; Thotakura AK; Bennett J; Moretti M; Franzoso G
    Trends Cell Biol; 2012 Nov; 22(11):557-66. PubMed ID: 22995730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NF-KB pathway and endocrine therapy resistance in breast cancer.
    Khongthong P; Roseweir AK; Edwards J
    Endocr Relat Cancer; 2019 May; 26(6):R369-R380. PubMed ID: 32013374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information transmission from NFkB signaling dynamics to gene expression.
    Maity A; Wollman R
    PLoS Comput Biol; 2020 Aug; 16(8):e1008011. PubMed ID: 32797040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of NFkB in Drug Addiction: Beyond Inflammation.
    Nennig SE; Schank JR
    Alcohol Alcohol; 2017 Mar; 52(2):172-179. PubMed ID: 28043969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling via the NFκB system.
    Mitchell S; Vargas J; Hoffmann A
    Wiley Interdiscip Rev Syst Biol Med; 2016 May; 8(3):227-41. PubMed ID: 26990581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Cell Cycle, RRM2 and NF-κB for the Treatment of Breast Cancers.
    Sultana N; Elford HL; Faridi JS
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Treatment with
    Uzzan S; Rostevanov IS; Rubin E; Benguigui O; Marazka S; Kaplanski J; Agbaria R; Azab AN
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339101
    [No Abstract]   [Full Text] [Related]  

  • 16. CYB561 promotes HER2+ breast cancer proliferation by inhibiting H2AFY degradation.
    Zhao T; Wang C; Zhao N; Qiao G; Hua J; Meng D; Liu L; Zhong B; Liu M; Wang Y; Bai C; Li Y
    Cell Death Discov; 2024 Jan; 10(1):38. PubMed ID: 38245506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells.
    Lim YJ; Kim HS; Bae S; So KA; Kim TJ; Lee JH
    Molecules; 2024 Jan; 29(1):. PubMed ID: 38202856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer-directs the road towards therapy resistance, metastatic progression and recurrence.
    Thakur D; Sengupta D; Mahapatra E; Das S; Sarkar R; Mukherjee S
    Cancer Metastasis Rev; 2024 Mar; 43(1):481-499. PubMed ID: 38170347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible Participation of Adenine Nucleotide Translocase ANT1 in the Cytotoxic Action of Progestins, Glucocorticoids, and Diclofenac on Tumor Cells.
    Ulchenko D; Miloykovich L; Zemlyanaya O; Shimanovsky N; Fedotcheva T
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients.
    Zhou Q; Zhang L; Dong Y; Wang Y; Zhang B; Zhou S; Huang Q; Wu T; Chen G
    Hypertens Res; 2024 Feb; 47(2):375-384. PubMed ID: 37872376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.